Similar articles

• Does sex affect anticoagulant use for stroke prevention in nonvalvular atrial fibrillation? The prospective global anticoagulant registry in the FIELD-Atrial Fibrillation.

  Lip GY, Rushton-Smith SK, Goldhaber SZ, Fitzmaurice DA, Mantovani LG, Goto S, Haas S, Bassand JP, Camm AJ, Ambrosio G, Janský P, Al Mahmeed W, Oh S, van Eickels M, Raatikainen P, Steffel J, Oto A, Kayani G, Accetta G, Kakkar AK; GARFIELD-AF Investigators. Lip GY, et al. Circ Cardiovasc Qual Outcomes. 2015 Mar;8(2 Suppl 1):S12-20. doi: 10.1161/CIRCOUTCOMES.114.001556. Epub 2015 Feb 24. Circ Cardiovasc Qual Outcomes. 2015. PMID: 25714828
• Anticoagulation for stroke prevention in elderly patients with non-valvular atrial fibrillation: what are the obstacles?

  Wong CW. Wong CW. Hong Kong Med J. 2016 Dec;22(6):608-15. doi: 10.12809/hkmj154803. Hong Kong Med J. 2016. PMID: 27920399 Review.
• Selection of Oral Anticoagulants in Ischemic Stroke Patients with Nonvalvular Atrial Fibrillation.

  Deguchi I, Tanahashi N, Takao M. Deguchi I, et al. J Stroke Cerebrovasc Dis. 2018 Oct;27(10):2627-2631. doi: 10.1016/j.jstrokecerebrovasdis.2018.05.036. Epub 2018 Jun 30. J Stroke Cerebrovasc Dis. 2018. PMID: 29970321
• Apixaban in the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation in France: Rationale and design of the PAROS cross-sectional study.

  Picard F, Ducrocq G, Danchin N, Falissard B, Hanon O, Mahe I, Touzé E, Steg PG. Picard F, et al. Arch Cardiovasc Dis. 2018 May;111(5):349-356. doi: 10.1016/j.acvd.2017.07.005. Epub 2017 Nov 27. Arch Cardiovasc Dis. 2018. PMID: 29191525
• Stroke prevention in atrial fibrillation.

  Freedman B, Potpara TS, Lip GY. Freedman B, et al. Lancet. 2016 Aug 20;388(10046):806-17. doi: 10.1016/S0140-6736(16)31257-0. Lancet. 2016. PMID: 27560276 Review.